top of page

Search Results

29 items found for ""

  • Hem Sol | Hememics

    Hem So l ™ HemStation Back Hem Sol ™ is the special desiccation solution that has enabled Hememics ™ to create our state-of-the-art technology. After 7 years of development, Hememics founder, Dr. David Ho, created a solution that strips biology of its moisture without denaturing its initial structure, Hem Sol ™ . Thanks to Hem Sol ™ , Hememics has been able to develop biosensors far faster, more accurate, and much more resilient than any other biosensors that currently exist. Next >

  • Home | Hememics

    Using graphene-based sensors and patented bio preservatives, Hememics brings handheld, lab-quality testing performance wherever needed Our low-cost platform consists of a portable, easy-to-use reader utilizing a single-use biochip with 32 sensors that can be individually programmed to detect molecular, antigen and antibody targets Hem Chip Hem Box Read More Read More Read More *Click on products to learn more* Hem Station ® ® ® We put a whole lab in your hand so you can make decisions when and wherever necessary – simplifying workflows with results within 5 minutes Environmental Hem Box ® and Hem Chip ® are convenient, resilient and reliable. The size of a smartphone and thumb respectively, they are both easily transportable. The BIOSENSOR system is also temperature resistant and ruggedized, making the Hem Box ® and HemChip ® perfect for field use

  • HemBox | Hememics

    Hem Box Impressively Fast & Precise ® HemBox Back < Previous The Hem Box ® biosensor system is a handheld, field hardened, e nviron mentally resilient analytical device made for rapid on-site identification of bio-hazards present in water, soil, and infected persons. ​ ​ The Hem Box ® can simultaneously identify multiple biological threats and yield sensitive, selective, and measurable data in real time. ​ This data can be stored on the device and transmitted once a Bluetooth device with a secure user account is within range. Next >

  • HemChip | Hememics

    He m Chi p Panel Development for Point of Care ® HemChip ® Back The Hem Chip ® is a small, portable, and disposable biosensor configured for multiplexing. ​ The Hem Chip ® is made with a bior eceptor layer and a proprietary biochip, designed to detect pathogens with utmos t speed, accuracy, and sensitivity. ​ Each Hem Chip ® contains multiple biosensors, enabling the detection of multiple pathogens simultaneously. The Hem Box ® and Hem Chip ® work in tandem, with the Hem Box ® interpreting the signals that the Hem Chip ® outputs, giving the user their real-time results in less than 5 minutes. ® ® < Previous Next >

  • John L. Warden, Jr. | Hememics

    Go back John L. Warden, Jr. Chairman & Co-Founder Co-Founder, CEO Entrepreneurial and executive roles in 5 start-up companies to date, returning more than $75M in net profits to investors. Successful business development experience with Biovista, a drug development services provider to major pharmaceutical companies. Significant impact building markets for technology products. Developed, engineered and constructed the proprietary software and hardware for the HemChip®, HemBox®, HemStation®. Previous Next

  • Publications | Hememics

    Hememics Related Publications

  • Richard Liu | Hememics

    < Back Go back A Bit About Richard Liu CFO Extensive professional experiences in capital markets, financial analysis, accounting and auditing ​MBA from Johnson Graduate School of Management, Cornell University; BBA from Baruch College, City University of New York. He is a CFA Charterholder and was a CPA in New York State.​ Successfully oversaw equity trading desk with hundreds of millions of shares of trading volume in the US, EU, and Japan and brought direct positive impact to P&L by leveraging technology to improve execution speed and quality with lower commissions. < Previous Next >

  • Platform | Hememics

    A low-cost platform consisting of a portable, easy-to-use reader utilizing a single-use biochip with 32 sensors that can be individually programmed to detect molecular, antigen and antibody targets ​ Platforms Hem Chip Hem Box Hem Station ® ® ® Read More Read More Read More *Click on pictures to know more* VS PCR test Lateral flow Compare to Hembox ® Compare to Hembox ® We put a whole lab in your hand so you can make decisions when and wherever necessary simplifying workflows with results within 5 minutes

  • Mary E. Schmidt, MD | Hememics

    Go back Mary E. Schmidt, MD Board member President, Schmidt & Libby Health Advisory Group Associate Professor of Clinical Medicine, VCU Dr. Schmidt is the President of Schmidt and Libby Health Advisory Group. She is board-certified in infectious diseases and internal medicine, has a master’s degree in Public Health from John Hopkins Bloomberg School of Public Health, and is an associate professor of Clinical Medicine at Virginia Commonwealth University. She practiced her specialty of infectious diseases for 25 years and has many awards and honors including the Best Physicians in America. In addition, Dr. Schmidt has had several leadership positions. She was Chief of Staff at the Inova Fairfax Medical Campus from 2010 through 2013 where she led the quality and citizenship activities of 2,400 physicians. She was a member of the Command Center at Inova Fairfax Hospital for Disaster and Bioterrorism Events and a member of the Inova Health System Oversight Committee for the roll out of the Epic medical record system. Dr. Schmidt has also held the position of Director of Transplant Infectious Diseases for 6 years at Inova Fairfax Hospital where she focused on the medical care of immunocompromised individuals and excellence in the care of transplant patients. Previous Next

  • Contact Us | Hememics

    Get in Touch Feel free to reach out to Hememics First Name Email Last Name Phone Number Subject Message By submitting this form, I acknowledge the receipt of the Hememics Privacy Policy Fields marked with an asterisk ( * ) are required. FAQ Send

  • John L. Warden, Jr. | Hememics

    < Back Go back A Bit About John L. Warden, Jr. Co-Founder & CEO Entrepreneurial and executive roles in 5 start-up companies to date, returning more than $75M in net profits to investors. Successful business development experience with Biovista, a drug development services provider to major pharmaceutical companies. Significant impact building markets for technology products. Developed, engineered and constructed the proprietary software and hardware for the HemChip®, HemBox®, and HemStation®. < Previous Next >

  • AACC Pictures | Hememics

    < Back WE WERE THERE! ADLM (AACC) 2023 conference was held in Anaheim CA Hememics' booth experienced a great amount of traffic and interest from many passerby Hememics team and investors at the booth David Ho, the CSO of Hememics, and John Warden, the CEO of Hememics. Hememics experienced lots of engagement from passerby where they were very interested in the 3 products showcased: the Hem Chip ® , Hem Box ® , and Hem Stati on ® < Back

bottom of page